RESMED INC — Director's Dealing 2013

Feb 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-01-30

Reporting Person: QUINN MICHAEL A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-30	ResMed Common Stock	M	3000	$9.798	Acquired	305000	Direct
2013-01-30	ResMed Common Stock	S	3000	$47.75	Disposed	302000	Direct
2013-01-31	ResMed Common Stock	M	9000	$9.798	Acquired	311000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-30	ResMed Common Stock Options	$9.798	M	3000	Acquired	2013-07-07	ResMed Common Stock (3000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Chess Depositary Instruments	400000	Direct
ResMed Chess Depositary Instruments	306000	Indirect

Footnotes

F1: Represents date options first became exercisable. Options vest 1/3 annually on the anniversary of the grant.

F2: These shares are held as CDIs on the Australian Securities Exchange which represents 24,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.

F3: These shares are held as CDIs on the Australian Securities Exchange which represents 30,600 NYSE shares. 1 NYSE share is equal to 10 CDIs.